Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 115 citing articles:

Phages for Biofilm Removal
Celia Ferriol-González, Pilar Domingo‐Calap
Antibiotics (2020) Vol. 9, Iss. 5, pp. 268-268
Open Access | Times Cited: 168
Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth
Stephen T. Abedon, Katarzyna Danis‐Wlodarczyk, Daniel J. Wozniak
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1019-1019
Open Access | Times Cited: 127
Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far
Marzanna Łusiak-Szelachowska, Ryszard Międzybrodzki, Zuzanna Drulis‐Kawa, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 113
Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future
Małgorzata Łobocka, Krystyna Dąbrowska, Andrzej Górski
BioDrugs (2021) Vol. 35, Iss. 3, pp. 255-280
Open Access | Times Cited: 103
Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study
Jean‐Paul Pirnay, Sarah Djebara, Griet Steurs, et al.
Nature Microbiology (2024) Vol. 9, Iss. 6, pp. 1434-1453
Open Access | Times Cited: 100
Translating phage therapy into the clinic: Recent accomplishments but continuing challenges
Aleksandra Petrović Fabijan, Jonathan R. Iredell, Katarzyna Danis‐Wlodarczyk, et al.
PLoS Biology (2023) Vol. 21, Iss. 5, pp. e3002119-e3002119
Open Access | Times Cited: 66
Phage Therapy—Challenges, Opportunities and Future Prospects
Beata Zalewska-Pia̧tek
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1638-1638
Open Access | Times Cited: 62
Bio-Inspired Nanomaterials for Micro/Nanodevices: A New Era in Biomedical Applications
Mohammad Harun‐Ur‐Rashid, Israt Jahan, Tahmina Foyez, et al.
Micromachines (2023) Vol. 14, Iss. 9, pp. 1786-1786
Open Access | Times Cited: 55
Bacteriophage Therapy: Developments and Directions
Mikeljon P. Nikolich, Andrey A. Filippov
Antibiotics (2020) Vol. 9, Iss. 3, pp. 135-135
Open Access | Times Cited: 126
High-throughput mapping of the phage resistance landscape in E. coli
Vivek K. Mutalik, Benjamin A. Adler, Harneet S. Rishi, et al.
PLoS Biology (2020) Vol. 18, Iss. 10, pp. e3000877-e3000877
Open Access | Times Cited: 126
Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application
Katarzyna Danis‐Wlodarczyk, Daniel J. Wozniak, Stephen T. Abedon
Antibiotics (2021) Vol. 10, Iss. 12, pp. 1497-1497
Open Access | Times Cited: 95
A combination therapy of Phages and Antibiotics: Two is better than one
Xianghui Li, Yuhua He, Zhili Wang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 13, pp. 3573-3582
Open Access | Times Cited: 94
Bacteriophage – A Promising Alternative Measure for Bacterial Biofilm Control
Fengjuan Tian, Jing Li, Amina Nazir, et al.
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 205-217
Open Access | Times Cited: 84
Recent progress toward the implementation of phage therapy in Western medicine
Jean‐Paul Pirnay, Tristan Ferry, Grégory Resch
FEMS Microbiology Reviews (2021) Vol. 46, Iss. 1
Closed Access | Times Cited: 67
Novel Strategies to Combat Bacterial Biofilms
Fatemeh Hemmati, Mohammad Ahangarzadeh Rezaee, Saba Ebrahimzadeh, et al.
Molecular Biotechnology (2021) Vol. 63, Iss. 7, pp. 569-586
Closed Access | Times Cited: 61
The Potential of Bacteriophage-Antibiotic Combination Therapy in Treating Infections with Multidrug-Resistant Bacteria
Abdul-Halim Osman, Fleischer C. N. Kotey, Alex Odoom, et al.
Antibiotics (2023) Vol. 12, Iss. 8, pp. 1329-1329
Open Access | Times Cited: 29
Retrospective, observational analysis of the first one hundred consecutive cases of personalized bacteriophage therapy of difficult-to-treat infections facilitated by a Belgian consortium
Jean‐Paul Pirnay, Sarah Djebara, Griet Steurs, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 26
Antibiotics that affect translation can antagonize phage infectivity by interfering with the deployment of counter-defenses
Benoît J. Pons, Tatiana Dimitriu, Edze R. Westra, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 4
Open Access | Times Cited: 25
The Biotechnological Application of Bacteriophages: What to Do and Where to Go in the Middle of the Post-Antibiotic Era
Su Jin Jo, Jun Kwon, Sang Guen Kim, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2311-2311
Open Access | Times Cited: 25
A Comprehensive Review on Phage Therapy and Phage-Based Drug Development
Longzhu Cui, Shinya Watanabe, Kazuhiko Miyanaga, et al.
Antibiotics (2024) Vol. 13, Iss. 9, pp. 870-870
Open Access | Times Cited: 15
Phage therapy: an alternative treatment modality for MDR bacterial infections
Namrata Pal, Poonam Sharma, Manoj Kumawat, et al.
Infectious Diseases (2024) Vol. 56, Iss. 10, pp. 785-817
Closed Access | Times Cited: 10
Exploring synergistic and antagonistic interactions in phage-antibiotic combinations against ESKAPE pathogens
Ashlan J. Kunz Coyne, Mirna Eshaya, Callan Bleick, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 10
Open Access | Times Cited: 8
Phage Therapy: The Pharmacology of Antibacterial Viruses
Katarzyna Danis‐Wlodarczyk, Krystyna Dąbrowska, Stephen T. Abedon
Current Issues in Molecular Biology (2020), pp. 81-164
Open Access | Times Cited: 61
Combination Therapy of Phage vB_KpnM_P-KP2 and Gentamicin Combats Acute Pneumonia Caused by K47 Serotype Klebsiella pneumoniae
Zijing Wang, Ruopeng Cai, Gang Wang, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 45
Phage therapeutics: from promises to practices and prospectives
Kanika Bhargava, Gopal Nath, Amit Bhargava, et al.
Applied Microbiology and Biotechnology (2021) Vol. 105, Iss. 24, pp. 9047-9067
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top